CLS vs. PME.AX

Last updated Jun 13, 2026

CLS (Celestica Inc.) and PME.AX (Pro Medicus Limited) are both stocks. CLS operates in Electronic Components (Technology), while PME.AX operates in Health Information Services (Healthcare). Over the past 10 years, CLS returned 43.71%/yr vs 42.98%/yr for PME.AX. At a 0.15 correlation, their price movements are largely independent.

Performance

CLS vs. PME.AX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Celestica Inc. (CLS) and Pro Medicus Limited (PME.AX). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CLS is traded in USD, while PME.AX is traded in AUD. To make them comparable, the PME.AX values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, CLS achieves a 32.99% return, which is significantly higher than PME.AX's -21.40% return. Both investments have delivered pretty close results over the past 10 years, with CLS having a 43.71% annualized return and PME.AX not far behind at 42.98%.

CLS

• 1D: 1.88%
• 1M: 5.52%
• YTD: 32.99%
• 6M: 28.26%
• 1Y: 200.71%
• 3Y*: 207.28%
• 5Y*: 116.26%
• 10Y*: 43.71%

PME.AX

• 1D: 0.67%
• 1M: 26.82%
• YTD: -21.40%
• 6M: -25.67%
• 1Y: -36.40%
• 3Y*: 38.20%
• 5Y*: 24.86%
• 10Y*: 42.98%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CLS vs. PME.AX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CLS Celestica Inc.	32.99%	220.27%	215.23%	159.80%	1.26%	37.92%	-2.42%	-5.70%	-16.32%	-11.56%
PME.AX Pro Medicus Limited	-21.40%	-4.61%	137.97%	74.08%	-16.69%	73.09%	68.64%	105.30%	13.34%	98.48%

Correlation

The correlation between CLS and PME.AX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.11
Correlation (All Time) Calculated using the full available price history since Jul 10, 2007	0.15

Return for Risk

CLS vs. PME.AX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLS

CLS Risk / Return Rank: 92
CLS Sharpe Ratio Rank: 95
CLS Sortino Ratio Rank: 88
CLS Omega Ratio Rank: 88
CLS Calmar Ratio Rank: 96
CLS Martin Ratio Rank: 95

PME.AX

PME.AX Risk / Return Rank: 15
PME.AX Sharpe Ratio Rank: 10
PME.AX Sortino Ratio Rank: 12
PME.AX Omega Ratio Rank: 11
PME.AX Calmar Ratio Rank: 21
PME.AX Martin Ratio Rank: 22

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLS vs. PME.AX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Celestica Inc. (CLS) and Pro Medicus Limited (PME.AX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CLS	PME.AX	Difference
Sharpe ratio: Return per unit of total volatility	2.78	-0.68	+3.46
Sortino ratio: Return per unit of downside risk	2.81	-0.78	+3.59
Omega ratio: Gain probability vs. loss probability	1.37	0.89	+0.48
Calmar ratio: Return relative to maximum drawdown	6.91	-0.55	+7.46
Martin ratio: Return relative to average drawdown	16.83	-0.96	+17.79

CLS vs. PME.AX - Sharpe Ratio Comparison

The current CLS Sharpe Ratio is 2.78, which is higher than the PME.AX Sharpe Ratio of -0.68. The chart below compares the historical Sharpe Ratios of CLS and PME.AX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CLS vs. PME.AX - Drawdown Comparison

The maximum CLS drawdown since its inception was -96.93%, which is greater than PME.AX's maximum drawdown of -85.69%. Use the drawdown chart below to compare losses from any high point for CLS and PME.AX.

Drawdown Indicators

	CLS	PME.AX	Difference
Max Drawdown Largest peak-to-trough decline	-96.93%	-85.69%	-11.24%
Max Drawdown (1Y) Largest decline over 1 year	-29.24%	-64.55%	+35.31%
Max Drawdown (3Y) Largest decline over 3 years	-53.96%	-64.55%	+10.59%
Max Drawdown (5Y) Largest decline over 5 years	-53.96%	-64.55%	+10.59%
Max Drawdown (10Y) Largest decline over 10 years	-80.60%	-66.87%	-13.73%
Current Drawdown Current decline from peak	-16.78%	-46.19%	+29.41%
Average Drawdown Average peak-to-trough decline	-73.31%	-29.03%	-44.28%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.98%	37.56%	-25.58%

Volatility

CLS vs. PME.AX - Volatility Comparison

Celestica Inc. (CLS) has a higher volatility of 27.54% compared to Pro Medicus Limited (PME.AX) at 15.11%. This indicates that CLS's price experiences larger fluctuations and is considered to be riskier than PME.AX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CLS	PME.AX	Difference
Volatility (1M) Calculated over the trailing 1-month period	27.54%	15.11%	+12.43%
Volatility (6M) Calculated over the trailing 6-month period	55.42%	49.90%	+5.52%
Volatility (1Y) Calculated over the trailing 1-year period	72.65%	52.01%	+20.64%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	57.70%	43.71%	+13.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.97%	45.02%	+4.95%

Dividends

CLS vs. PME.AX - Dividend Comparison

CLS has not paid dividends to shareholders, while PME.AX's dividend yield for the trailing twelve months is around 0.38%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CLS Celestica Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PME.AX Pro Medicus Limited	0.38%	0.25%	0.16%	0.31%	0.40%	0.24%	0.35%	0.31%	0.55%	0.46%	0.62%	0.60%

Financials

Frequently Asked Questions

Can I hold both CLS and PME.AX in my portfolio?

CLS and PME.AX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.